These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 3004712

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells.
    Pommier Y, Zwelling LA, Kao-Shan CS, Whang-Peng J, Bradley MO.
    Cancer Res; 1985 Jul; 45(7):3143-9. PubMed ID: 2988762
    [Abstract] [Full Text] [Related]

  • 24. Effect of retinoic acid on DNA cleavage and cytotoxicity of topoisomerase II-reactive drugs in a human head and neck squamous carcinoma cell line.
    Kim HK, Zwelling LA, Sacks PG, Hong WK, Chan D, Silberman L, Glisson BS.
    Cancer Res; 1989 Mar 01; 49(5):1197-201. PubMed ID: 2537145
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Enhancement of the DNA breakage and cytotoxic effects of intercalating agents by treatment with sublethal doses of 1-beta-D-arabinofuranosylcytosine or hydroxyurea in L1210 cells.
    Minford J, Kerrigan D, Nichols M, Shackney S, Zwelling LA.
    Cancer Res; 1984 Dec 01; 44(12 Pt 1):5583-93. PubMed ID: 6208999
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Alterations in the topoisomerase II alpha gene, messenger RNA, and subcellular protein distribution as well as reduced expression of the DNA topoisomerase II beta enzyme in a mitoxantrone-resistant HL-60 human leukemia cell line.
    Harker WG, Slade DL, Parr RL, Feldhoff PW, Sullivan DM, Holguin MH.
    Cancer Res; 1995 Apr 15; 55(8):1707-16. PubMed ID: 7712479
    [Abstract] [Full Text] [Related]

  • 31. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts.
    Zwelling LA, Estey E, Silberman L, Doyle S, Hittelman W.
    Cancer Res; 1987 Jan 01; 47(1):251-7. PubMed ID: 3024817
    [Abstract] [Full Text] [Related]

  • 32. Altered topoisomerase I and II activities in suramin-resistant lung fibrosarcoma cells.
    Lelièvre S, Benchokroun Y, Larsen AK.
    Mol Pharmacol; 1995 May 01; 47(5):898-906. PubMed ID: 7746278
    [Abstract] [Full Text] [Related]

  • 33. Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions.
    Zwelling LA, Mayes J, Hinds M, Chan D, Altschuler E, Carroll B, Parker E, Deisseroth K, Radcliffe A, Seligman M.
    Biochemistry; 1991 Apr 23; 30(16):4048-55. PubMed ID: 1850298
    [Abstract] [Full Text] [Related]

  • 34. Effects of the bifunctional antitumor intercalator ditercalinium on DNA in mouse leukemia L1210 cells and DNA topoisomerase II.
    Markovits J, Pommier Y, Mattern MR, Esnault C, Roques BP, Le Pecq JB, Kohn KW.
    Cancer Res; 1986 Nov 23; 46(11):5821-6. PubMed ID: 3019538
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The 1'-substituent on the anilino ring of the antitumor drug amsacrine is a critical element for topoisomerase II inhibition and cytotoxicity.
    Rene B, Fosse P, Khelifa T, Jacquemin-Sablon A, Bailly C.
    Mol Pharmacol; 1996 Feb 23; 49(2):343-50. PubMed ID: 8632768
    [Abstract] [Full Text] [Related]

  • 38. The influence of DNA-topoisomerase II inhibitors novobiocin and fostriecin on the induction and repair of DNA damage in Chinese hamster ovary (CHO) cells treated with mitoxantrone.
    Stĕtina R, Veselá D.
    Neoplasma; 1991 Feb 23; 38(1):109-17. PubMed ID: 1849236
    [Abstract] [Full Text] [Related]

  • 39. DNA topoisomerases in cancer therapy.
    Lock RB, Ross WE.
    Anticancer Drug Des; 1987 Oct 23; 2(2):151-64. PubMed ID: 2835059
    [Abstract] [Full Text] [Related]

  • 40. Reversal of "atypical"-multidrug resistance by recombinant human tumor necrosis factor in the human ovarian cancer cell line A2780-DX3.
    Cimoli G, Valenti M, Parodi S, Mazzoni A, De Sessa F, Conte P, Russo P.
    Oncol Res; 1993 Oct 23; 5(8):311-23. PubMed ID: 8012063
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.